SERUM LEVEL OF SOLUBLE INTERLEUKIN-2 RECEPTOR ALPHA AS A PREDICTOR OF TREATMENT RESPONSE IN BRUCELLOSIS
Abstract
Introduction: Iran is one of the endemic regions with high prevalence of brucellosis. Severalserological markers for diagnosis and response to treatment are available. Serum level of Soluble
Interleukin-2 Receptor alpha (SIL-2Rα) is a new marker to assess response to therapy and clinical
relapse of brucellosis. This study intends to investigate the serum levels of SIL-2Rα before and
after treatment, to evaluate this marker for patients responding to treatment of brucellosis.
Methods: This study is an analytical cross-sectional study. Forty patients who had clinical signs of
brucellosis and serological tests confirmed the disease have been treated with standard antibiotics
for 6 weeks. 2ME and SIL-2Rα levels were measured before and after treatment and these values
were compared. Results: Among the 40 patients, 27 patients (67.5%) had improvement in
symptoms and 13 patients (32.5%) had no symptoms after treatment. In Comparing serum levels of
SIL-2Rα and 2ME before and after treatment, decreasing of both markers after treatment was
significant (p<0.001). In patients with false positive for 2ME, SIL-2Rα in 57% of patients had a
reduction, but in patients with false negative for 2ME, SIL-2Rα in only 28% of patients increased.
Conclusion: Not only is Serum level of SIL-2Rα useful for predicting response to treatment of
brucellosis, but also in cases of false positive of 2ME can be helpful.
Keywords: Brucellosis, SIL-2Rα, 2ME
References
Longo DL, Fauci AS, Kasper DL. Harrison's Principles of
Internal Medicine, McGraw-Hill Professional; 18th ed., 2011.
Galanakis E, Bourantas KL, Leveidiotou S, Lapatsanis PD.
Childhood brucellosis in north - western Greece : a retrospective
analysis. Eur J Pediatr 1996;155:1-6.
Hadadi A, Rasoulinezhad Mehrnaz, Afhami Sh, Mohraz M.
Epidemiological, Clinical, Para clinical Aspects of Brucellosis in
Imam Khomeini and Sina Hospital of Tehran (1998-2005). J
Kermanshah Univ Med Sci, Iran 2006;10(3):242.
Baldwin CL, Winter AJ. Macrophages and Brucella. Immunol
Ser 1994;60:363-80 .
Shapoury R, Imani Fooladi AA, Rahnama M, Izadi M.
Designing and validation of indirect and competitive ELISA for
diagnosis of Brucellosis in human. J Military Med.
;11(1):17-8.
Zaitseva MB, Golding H, Betts M. Human peripheral blood
CD4C and CD8CT-cells express Th1-like cytokine mRNA and
proteins following in vitro stimulation with heat-activated
Brucella abortus. Infect Immun 1995;63:2720-8 .
Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and
interleukin-12 contribute to resistance to the intracellular
bacterium Brucella abortus by different mechanisms. Infect
Immun 1996;64:2782-6.
Kamal Esalatmanesh, Zahra Soleimani, Abbas Arj, Hossein
Akbari, Mansour Salesi. Diagnostic value of ELISA (IgG and
IgM) test in brucellosis patients in Kashan during 2004. Feyz
;3:54-9.
Agranovich I, Scott DE, Terle D, Lee K, Golding B. Down
regulation of Th2 responses by Brucella abortus, a strong Th1
stimulus, correlates with alterations in the B7.2-CD28 pathway.
Infect Immun 1999;67:4418-26.
Saleh P. Diagnostic value of brucella (IgM and IgG) in patients
with brucellosis in Kashan. Infect Dis 1999;44:59-63. [Article in
Persian]
Alexandros C. Makis, Emmanouil Galanakis, Eleftheria C.
Hatzimichael, Zoe L. Papadopoulou, Antigone. Serum level of
soluble interleukin-2 receptor alpha (SIL-2Rα) as a predictor of
outcome in brucellosis J Infect 2005;51:206-10.
Skendros P. Diminished Percentage of CD4+ T-lymphocytes
expressing interleukine-2receptor alpha in chronic brucellosis. J
Infect 2007;54(2):192-7.
Honda M, Kitamura K, Takeshita T, Sugamura K, Tokunaga T.
Identification of a soluble IL-2 receptor beta-chain from human
lymphoid cell line cells. J Immunol 1990;145:4131-5.
Galanakis E, Makis A, Bourantas KL, Papadopoulou ZL.
Interleukin-3 and interleukin-4 in childhood brucellosis. Infection
;30:33-4.
Downloads
Published
How to Cite
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
